Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the sixteenth meeting of the seventh board of directors on September 15, 2021, and resolved to convene the company's 2021 third extraordinary general meeting of shareholders
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or the "Company") received a notice from the controlling shareholder Yiling Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Yiling Pharmaceutical Technology") on September 17, 2021. Yiling Pharmaceutical Technology releases part of the company's shares held by it from the pledge Securities code: 002603 Securities abbreviation: Yiling Pharmaceutical Announcement Number: 2021-077 Shijiazhuang Yiling Pharmaceutical Co., Ltd.Announcement on the Release of Part of the Pledge of Controlling Shareholders The company and all members of the board of directors guarantee the truthfulness, accuracy and completeness of the information disclosed, and there are no false records, misleading statements or major omissions. Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or the "Company") received a notice from the controlling shareholder Yiling Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Yiling Pharmaceutical Technology") on September 17, 2021. Yiling Pharmaceutical Technology released some of its shares in the company from the pledge. The specific matters are as follows: 1. The basic situation of the shareholders' partial release of the pledge 1. The basic situation of shareholders’ shares released this time from the pledge Shareholder name Whether it is the controlling shareholder or the largest shareholder and the person acting in concert Number of pledges released this time (shares) Percentage of shares held by it Percentage of the company's total equity Starting date Cancellation day Pledgee Yiling Pharmaceutical Technology Co., Ltd. The company's largest shareholder 42,000,000 7.97% 2.51% 2021 Nian 4 Yue 7 Ri 2021 Nian 9 Yue 16 Ri China Merchants Wealth Asset Management Co., Ltd. 2. Cumulative pledge of shareholder shares As of the announcement date, the pledged shares held by the above shareholders and their concerted parties are as follows: Shareholder name Number of shares held (shares) Shareholding ratio Cumulative number of pledged shares (shares) Percentage of shares held by it Percentage of the company's total equity Pledged shares Unpledged shares The number of pledged shares restricted and frozen (shares) Percentage of pledged shares Unpledged shares restricted and frozen quantity (shares) Percentage of unpledged shares Yiling Pharmaceutical Technology Co., Ltd. 526,775,963 31.53% 49,000,000 9.30% 2.93% —— —— —— —— Wu Xiangjun 347,728,119 20.81% 28,476,000 8.19% 1.70% —— 0.00% 260,796,089 81.69% Wu Rui 39,096,008 2.34% 9,716,000 24.85% 0.58% 3,886,400 40.00% 25,435,606 86.57% total 913,600,090 54.68% 87,192,000 9.54% 5.22% 3,886,400 4.46% 286 , 231 , 695 34.64% (Note: The restricted shares held by Wu Xiangjun and Wu Rui are senior executives locked shares, so the "restricted and frozen number of pledged shares" and the "restricted and frozen number of unpledged shares" in the above table are all locked shares of senior executives. .) Yiling Pharmaceutical Technology has a good credit status, has a good fund repayment ability, and the pledge risk is controllable, and there is no substantial fund repayment risk. The aforementioned pledge behavior will not lead to changes in the company's actual control rights, and will not affect the company's production operations and corporate governance. If there is a risk of liquidation, Yiling Pharmaceutical Technology will take measures such as supplementary pledge and repurchase of pledged shares in advance to deal with the risk. 2. Documents for reference China Securities Depository and Clearing Co., Ltd. share freeze details. Special announcement. Shijiazhuang Yiling Pharmaceutical Co., Ltd. Board of Directors September 18, 2021
